ClinVar Miner

Submissions for variant NM_002024.6(FMR1):c.797G>A (p.Gly266Glu)

dbSNP: rs1569545763
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV002318889 SCV000851977 likely pathogenic Inborn genetic diseases 2019-02-01 criteria provided, single submitter clinical testing The p.G266E variant (also known as c.797G>A), located in coding exon 8 of the FMR1 gene, results from a G to A substitution at nucleotide position 797. The glycine at codon 266 is replaced by glutamic acid, an amino acid with similar properties. This alteration was detected as maternally inherited in an individual with a diagnosis of Fragile X syndrome who did not carry the typical repeat expansion mutation. This alteration was not detected in this individual's three unaffected brothers. In addition, authors used in vitro assays to show that this alteration impaired several FMRP protein functions (Myrick LK et al. Eur. J. Hum. Genet., 2014 Oct;22:1185-9). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.